Register for OBR daily


KH_ASCO_Webinar_300x250

To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

GALE $2.29 0.2100 +10.10%
EPZM $23.35 1.6900 +7.80%
SPPI $7.18 0.2800 +4.06%
BDSI $8.66 0.1900 +2.24%
NYMX $5.24 0.0900 +1.75%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

PARD $0.21 -0.1099 -34.34%
IMNP $3.96 -0.5300 -11.80%
TGTX $5.16 -0.6600 -11.34%
IMMU $4.15 -0.4200 -9.19%
GERN $2.00 -0.1900 -8.68%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 888 | 889 | 890 | 891 | 892 | 893 | 894 | 895 | 896 | 897 | Next > | Last >>

Hormel Institute Study Reveals Capsaicin Can Act as Cocarcinogen

(University of Minnesota) September 2, 2010 - The September cover story of the nation’s leading cancer journal, “Cancer Research,” features a new study from The Hormel Institute, University of Minnesota, that links capsaicin, a component of chili peppers, to skin cancer.
read press release 



Celgene Seeks to Stop Natco's Generic Revlimid

(Reuters) September 3, 2010 - Celgene Corp said it plans to file a complaint alleging infringement against India's Natco Pharma Ltd, which has submitted a request to the U.S. Food and Drug Administration for authorization to make and sell generic versions of Celgene's cancer drug Revlimid in the United States.
read article 



World of E Cigarettes: American Cancer Society Shuns E Cigarettes in Favor of the Real Thing

(Reuters) September 3, 2010 - The American Cancer Society continues to attack electronic cigarettes and falsely label them as dangerous and ineffective, while the number of people using the products is increasing by 20,000 to 30,000 a week.
read article 



China Cooking-Oil Maker Says Cancer-Causing Chemical in Product

(San Francisco Chronicle) September 2, 2010 - Jinhao Camellia Oil Corp., a Chinese maker of cooking oils, said about 42.5 tons of one of its products contained excessive amounts of a cancer-causing chemical.
read article 



Celsion Receives SBIR Grant To Expand Its Technology Platform

(Yahoo! Finance) September 2, 2010 - Celsion Corporation, a biotechnology drug development company, announced today that it has been awarded a competitive Phase I Small Business Innovation and Research (SBIR) grant from the National Institutes of Health (NIH), to support the proposal, "New Thermal Sensitive Carboplatin Liposomes for Cancer".
read article 



Vanderbilt-Ingram Cancer Center Opens Expanded Cancer Clinic

(Vanderbilt-Ingram) September 2, 2010 - Vanderbilt-Ingram Cancer Center has unveiled its newly expanded waiting area and additional clinic examination rooms for cancer patients and their families. The new, 10,000- square- foot space is located on the first floor of The Vanderbilt Clinic, across from the existing Cancer Center reception area.
read press release 



Patient Access and Reimbursement Challenges and Opportunities to be Addressed at AccessMED’s Patient Access Summit

(US Oncology) September 2, 2010 - Today’s healthcare reform environment brings new patient access and reimbursement implications to the pharmaceutical industry.
read press release 



Michael Douglas: 31 Days in the Life of a Throat Cancer Patient

(ABC News) September 3, 2010 - Another throat cancer patient tells of working his way through treatment, side-effects.
read article 



Opinion: Surer Footing for Medicare

(Washington Post) September 3, 2010 - Former health and human services secretary Michael Leavitt was incorrect in calling the Affordable Care Act's Medicare reforms an "illusion" ["The wrong prescription for Medicare," Washington Forum, Aug. 27].
read article (free registration required) 



Novartis Malaria Drug May Yield First New Treatment in 30 Years

(Bloomberg) September 2, 2010 - An experimental Novartis AG medicine that killed drug-resistant malaria in laboratory studies may become the first new class of treatment against the disease in 30 years, researchers said.
read article 



Special Report: Outgunned FDA Tries to Get Tough with Drug Ads

(Reuters) September 3, 2010 - In February 2009, a popular New York blogger attended a brunch with fellow "frazzled moms." They took in tips from a style expert and listened to a nurse extol the virtues of Mirena, a birth control device sold by Bayer Healthcare.The nurse was on Bayer's payroll.
read article 



Ads for Sleep Aid, HIV Drug Among Those Warned by FDA

(Reuters) September 3, 2010 - The following are details of some recent FDA warnings sent to drugmakers over misleading or inappropriate advertising, along with the dates the letters were made public.
read article 



Roche to Cut Costs, Review Business After Drug Setbacks

(Reuters) September 3, 2010 - Swiss drugmaker Roche Holding AG will review its business and cut costs to cope with recent setbacks on key drugs and rising pressures on prices from healthcare reforms, it said on Friday.
read article 



Abbott Abandons Plans to Sell Vaccines Business

(New York Times) September 3, 2010 - Drug and medical device firm Abbott Laboratories says it has abandoned plans to sell its vaccines unit, less than three months after exploring sales talks with rival companies.
read article (free registration required) 



Cancer Drug Points Way to New Alzheimer's Approach

(Reuters) September 1, 2010 - An altered version of the cancer drug Gleevec could form the basis of a new class of drugs that block the development of brain-damaging plaques in Alzheimer's disease, U.S. researchers said on Wednesday.
read article 



AIDS Cure Quest to Kill `Sleeping' Viruses Enlists Merck Cancer Medicine

(Bloomberg) September 2, 2010 - The 30-year-long search for a cure for AIDS, the world’s deadliest viral infection, may get a renewed boost from an unlikely source: a little-used Merck & Co. cancer drug.
read article 



Rexahn Pharmaceuticals Announces Publication of New Preclinical Research Data for Novel Anticancer Compound RX-8243

(MarketWatch) September 2, 2010 - Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced the publication of a research article in Bioorganic & Medicinal Chemistry Letters on the anti-tumor activity of RX-8243 and its analogues.
read article 



Chemopreventative Effects of Protandim® Examined Further in New Peer-Reviewed Study

(Yahoo! Finance) September 2, 2010 - Protandim's ability to modulate relationship between superoxide dismutase and tumor suppressor p53 believed responsible for reduction of skin cancers in mice.
read article 



Medicare Cuts Threaten Specialist Services

(Utica Observer-Dispatch) September 1, 2010 - Hematology-Oncology Associates of Central New York stopped providing chemotherapy at its Rome office as of Sept. 1, a move necessitated by recent cuts in Medicare payments, officials said.
read article 



Oncolytics Stock Rises on Cancer Study Approval

(Reuters) September 2, 2010 - Oncolytics Biotech Inc stock climbed as much as 7 percent on Thursday after it said a mid-phase ovarian cancer study involving its proprietary formulation of the human reovirus was approved.
read article 



Seattle Genetics Achieves Milestone Under Antibody-Drug Conjugate Collaboration with Agensys, an Affiliate of Astellas

(Forbes) September 2, 2010 - Seattle Genetics, Inc. announced today that it has achieved a milestone under its antibody-drug conjugate (ADC) collaboration with Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc.
read article 



Prostate Cancer-Linked Chemical Prompts Alert on Baby-Food Cans

(Bloomberg Businessweek) September 1, 2010 - A chemical linked with prostate cancer and infertility should be eliminated from cans and plastics used to package food for babies and young children, a consumer advocacy group said.
read article 



President Obama Declares September 2010 'National Prostate Cancer Awareness Month'

(StreetInsider) September 1, 2010 - On August 31, President Barack Obama signed a presidential proclamation designating September 2010 as 'National Prostate Cancer Awareness Month," stating: "Until we find a cure for this disease, my Administration will continue promoting awareness of this illness and supporting prostate cancer research and treatment."
read article 



Susan G. Komen San Francisco Race for the Cure(R) Celebrates Its 20th Anniversary

(Yahoo! Finance) September 1, 2010 - More than 7,000 people of all ages are expected to gather on Sunday, September 26, 2010, along the Embarcadero for the 20th Annual Susan G. Komen San Francisco Race for the Cure®.
read article 



EmpowHER Offers FREE Resources and Support to Women Living With Ovarian Cancer

(Yahoo! Finance) September 1, 2010 - EmpowHER is offering free access to world-class health information as well as a supportive community for women diagnosed with ovarian cancer.
read article